STRATEGIES FOR CLEANING

Size: px
Start display at page:

Download "STRATEGIES FOR CLEANING"

Transcription

1 STRATEGIES FOR CLEANING AND CLEANING VALIDATION THAT MINIMIZE DOWNTIME FOR PRODUCT CHANGEOVERS JOHN HYDE HYDE ENGINEERING + CONSULTING

2 PRESENTATION OUTLINE Importance of Cleaning Process Development at Lab and Pilot Scale for Transfer to Commercial Scale Equipment to Support Effective and Efficient Cleaning Operations Commercial Scale Cleaning Cycle Development Strategies that Enable Expeditious Cleaning of Process Equipment for Product Changeover Cleaning Circuit Configurations that Minimized the Number of Cleaning Cycles per Lot of Product Manufactured FDA Process Validation Guidance Three Stages of Validation Importance of Cleaning Cycle Development Lab and Pilot Scale Methodologies Commercial Scale Testing Strategies Ongoing Monitoring Statistical Analytical Methodologies Application of PAT to CIP Operations

3 CLEANING AND QUALIFICATION OBJECTIVES Primary Operational Concerns Product and Patient Safety Cleaning Consistency Cleaning Quality Cost Effectiveness Bases of Assessment of Cleaning Validation Acceptance Criteria Based Upon Well Understood Design Space Scientifically Proven Operating Ranges Testing Scale Lab, Pilot Plant, Commercial Plant Risk Bases of Cycle Development, Full Scale Testing and Ongoing Monitoring

4 TRADITIONAL APPROACH TO VALIDATION Established, Highly Controlled Procedure Three Consecutive, Successful Commercial Runs Confidence Placed in the Consistent Performance of the Controlled Procedure Every Time Some Late Stage Cleaning Cycle Development Often Occurs During Validation At The Time Of Commercial Manufacture Excursions/Deviations Are Evaluated and Compared to Historical Norms

5 RISK BASED APPROACH TO VALIDATION Focused on Cleaning Cycle Development Validation Studies Design and Execution Based Upon Risk Analysis and Management Buffer Prep and Holding Versus Final Filling Established Process Design Space Provides Identification of Critical Control Parameters and Boundary Conditions for Effective and Tight Process Controls Ongoing Monitoring of Critical Cleaning Parameters Provides Bases of Risk Review and Management With Ongoing Real Time Confirmation of Process Operation Within Validated Design Space Monitoring Sampling Plan Based Upon Risk

6 NEW APPROACHES TO CLEANING QUALIFICATION AND MONITORING Utilization of FDA 2011 Process Validation Guidance Approaches for Bases of Cleaning Validation Program Extensive Utilization of Risk Analysis and Management to Establish Focus Areas for Cleaning Validation and Ongoing Monitoring Development of Existing and New In-Process Material Residue Matrix from Laboratory and Pilot Scale Cleaning Data Usage of Residue Matrix Data for Determination of Extent of Full Scale Cleaning Validation Testing (e.g., Utilization of Laboratory Derived Data and Residue Matrices Rather Than Three Full-Scale Runs for Validation of Cleaning for New Products)

7 NEW APPROACHES TO CLEANING QUALIFICATION AND MONITORING Generation of Product Inactivation Data to Justify Analytical Methodologies and Residue Limits for Multi-Product Facilities Residue Limits not Based Upon MAC Calculations Unless Residues Contain Significant Levels of Active Drug Product Usage of PAT Methodologies and Data for Basis of Initial Cleaning Validation Studies and On-Going Monitoring for Defining Re-Validation Requirements

8 NEW CLEANING PRACTICES FOR CLEANING OF MULTIPRODUCT PROCESS EQUIPMENT Re-Use of Elastomers Between Manufacturer of Different Products Utilization of Normal Cleaning Cycles Between Manufacturer of Different Products Limited Cleaning Verification Between Manufacturer of Different Products if Justified by Existing Lab and Pilot Scale Cleaning Data

9 CLEANING CIRCUIT DESIGN OPTIMIZATION CIP circuits are configured such that each vessel, its inlet piping and its outlet piping are cleaned as separate CIP circuits This results in 2 to 3 times as many cleaning cycles per lot than if the vessels and inlet and outlet piping are cleaned together in one circuit Cleaning circuit system flow path sequencing used to clean interconnecting piping attached to vessels and piping branches in piping circuits Cleaning flow paths grouped to optimize flow rates or downstream pressure drops Cleaning flow path groupings optimized based upon post production residue contact 9

10 2011 GUIDANCE-BASED PRACTICES New guidance describes process validation activities in three stages Stage 1: Process design Stage 2: Process qualification Stage 3: Continued process verification Stated another way, process validation may be defined as: Process Validation = Lab Studies + Development History + Commercial Scale Target Values + Ongoing Monitoring

11 STAGE 1 CLEANING DESIGN Test Plan Author an experimental test plan describing the approach used to conduct bench scale cleaning process developmental studies for post production residues. Cleaning Agent Selection Test each residue using a designed experiment to screen alkaline, neutral, and acidic post production residues over a range of typical cleaning process temperatures to determine an appropriate cleaning agent for a particular post production residue.

12 STAGE 1 - CLEANING DESIGN Cleaning Process Design Space Exploration Using the appropriate cleaning agent, explore combinations of temperature, turbulence, and concentration to assess the response of removal rate over typical ranges of these process variables via a DOE based study Worst Case Residue Evaluation Compare the removal rates of selected post production residues to empirically determine which are worst case with respect to the cleaning process

13 TESTING METHODOLOGY 5 cm ~1 in 2 5 cm Consistent soiling Amount of material Reproducible surface area Control Dirty Hold Time Cleaning Process Control PID Temperature Control Controlled Agitation Precisely Formulated cleaning solutions

14 DETERMINING REYNOLDS NUMBER - density - viscosity N Impeller speed in revolutions per second D Impeller Diameter N Re < 2100 N Re > 3000 Laminar Example: T=25ºC D = 2 ( m) = 997 (kg/m 3 ) µ = poise N = 64 rpm (1.07 rps) N Re = 3082 Turbulent Agitated Immersion: N Re 2 D N 2

15

16

17 COUPON SOILING Representative Post- Production Residue Applied to Coupon Soiled Coupon Dried to Simulate Post- Production Conditions

18 COUPON TESTING

19 GRAVIMETRIC ASSESSMENT Laboratory Microbalance Accuracy ± grams Tare mass of coupons Amount of residue spiked on coupons Amount of residue remaining after cleaning assessment

20 Rate of Removal [mg/sec] RANGE FINDING RESULTS Range Finding Tests Water 25C Water 65C COSA-CIP-92 25C COSA-CIP-92 65C COSA-CIP-72 25C COSA-CIP-72 65C COSA-PUR-80 25C COSA-PUR-80 65C Duration [sec]

21 % Residue Remaining WORST CASE RESIDUE IDENTIFICATION 100% % Removal vs. Time A B 90% C D 80% 70% 60% 50% 40% E G I K F H J L 30% Q M 20% 10% 0% Cleaning duration (seconds) N P O

22 COSA-CIP-72 [ph2] COSA-CIP-72 [ph2] COSA-CIP-72 [ph2] Distilled Water [ph7] Distilled Water [ph7] Distilled Water [ph7] COSA-PUR-80 [ph7] COSA-PUR-80 [ph7] COSA-PUR-80 [ph7] COSA-CIP-92 [ph12] COSA-CIP-92 [ph12] COSA-CIP-92 [ph12] Average Removal Rate [mg/sec] EFFECTS OF PH AND TEMPERATURE 7 Average Removal Rate [mg/sec] % Detergent and Temperature [ C]

23 SURFACE RESPONSE PLOT Surface Plot of Rate vs Temp, ph 6 Rate ph Temp 60

24 TURBULENCE ASSESSMENT AND SCALE-UP CIP Supply Re 34,000 CIP Return Re 3,000 CIP System Variable Low Level (-) High Level (+) Concentration 1% 2% Temperature 25 C 65 C Energy N Re 3,000 34,000

25 TECH TRANSFER TO COMMERCIAL SCALE Protein Containing Residues Full CIP (Rinses, Alkaline Wash and Acid Wash) Buffer Containing Residues Typically Rinse Only Periodic Full CIP for Maintenance Purposes Cleaning Cycle Critical Parameters Grouped by Residues Media, Buffer, Cell Culture and Harvest, and Purification Residue-Based CCCPs Provide for More Effective and Economical Cleaning One Cycle Fits All Approach Very Ineffient and my also be Ineffective

26 TECH TRANSFER TO COMMERCIAL SCALE Input of Critical Cleaning Control Parameters (CCCPs) Analysis of CIP Cycle Operational Sequence Input of CIP Cycle into Control System Setpoint Format Hydraulic Balancing Equally Important to Implementation of CCCP Values Cleaning Efficacy Confirmed with Concurrent Process Validation and Cleaning Validation Runs

27 PRODUCT FRAGMENTATION/INACTIVATION Conduct Studies to Show Fragmentation / Inactivation of Active Molecule by Cleaning Process Expose Formulated Bulk Product to Cleaning Solutions at Use Strength and Temperature Analyze Residues with SDS-Page and Western Blot to Prove Fragmentation / Inactivation Favorable Results Justify Non-Product Specific Residue Testing Methods, Re-Use of Elastomers and Utilization of Normal CIP Cycles Between Manufacture of Different Products

28 STAGE 2 CLEANING QUALIFICATION During this stage, the cleaning cycle design is confirmed as being capable of effective and reproducible at commercial manufacturing scale Cleaning cycles challenged with typical post-production residues Dirty and clean hold times also assessed Qualification of the facility, utilities and equipment is required Cleaning systems, clean and plant utilities and process equipment systems are of primary interest

29 STAGE 2 CLEANING QUALIFICATION Usually run at operating parameter set points within proven acceptable range or design space Boundary condition testing is not typically performed at this stage as it has been assessed in Stage 1 May require additional testing to prove the process Qualification testing typically requires the analyses of more samples than for ongoing monitoring of cleaning Risk analysis used to determine extent of testing requirements Equipment and residue groupings used to determine testing requirements

30 CIP CYCLE, PHASE AND STEP HIERARCHY CIP Phases # Example Cycle Description Full CIP Drain Cycle Rinse Cycle Acid Wash Pre-Rinse Alk. Wash Post Rinse Air Blow & Drain Full CIP Cycle Wash Supply Air Blow RInse Final Rinse Supply Air Blow Final Drain # Example Phase Description 1 Rinse Phase 2 Post Rinse 3 Alkaline Wash 4 Final Rinse # Example Step Description 1 Check Interlocks 2 Fill Water Tank 3 Air Blow 4 Delay to Conductivity CIP Steps

31 STAGE 3 CONTINUED CLEANING VERIFICATION Ongoing assurance that cleaning is in control Monitor, collect information, assess, continuous verification, cleaning process improvements No longer revalidation, instead ongoing periodic evaluation 21 CFR (e) Annual review to determine whether changes in specifications or manufacturing or control procedures are needed Study trends, OOS/OOT to make improvements Feedback into design stage for significant process shifts or changes

32 CONFIRMATION OF CCCPS IN REAL TIME Essential for Control and Ongoing Monitoring of Cleaning Parameters Factors Affecting Cleaning Efficiency Measured via: Supply/Return Temperature Supply Flow Rate Supply Pressure Supply/Return Conductivity

33

34 TRADITIONAL VS. QBD APPROACHES Aspects Traditional QbD Cleaning Development Empirical; typically single variable experiments Systematic; multi variable experiments Cleaning Process Fixed Adjustable within design space; opportunities for innovation (PAT) Cleaning Control Cleaning Specification Control Strategy Lifecycle Management Annual re-validation; very risky because of product quality implication of test failures Primary means of quality control; based on cycle completion w/o errors Black-box; Validated cycles are relied upon as basis of cleaning success Reactive to problems and OOS; improvements driven by CAPAs and remediations PAT utilized for feedback and feed forward at real time and ongoing monitoring Part of the overall quality control strategy; based on operation within design space Data-based; monitoring and analysis of critical parameters Continual improvement enabled within design space

35 SUMMARY Risk Based Approach to Validation Results in More Comprehensive and Effective Result FDA Process Validation Guidance Three Stages of Validation Provides Excellent Basis to Cleaning Validation Study Design Importance of Cleaning Cycle Development Studies Crucial to Commercial Scale Success Ongoing Monitoring Provides Real-Time Assurance of Cleaning Efficacy

36 CONTACT INFO John M. Hyde, B.Sc., M.Sc. Principal Consultant Chairman and Founder Hyde Engineering + Consulting, Inc. john.hyde@hyde-ec.com

Validation Strategies for Multiproduct Manufacturing

Validation Strategies for Multiproduct Manufacturing Cleaning and Cleaning Validation Strategies for Multiproduct Manufacturing Facilities John M. Hyde Chairman and Founder Hyde Engineering + Consulting, Inc. Hyde Engineering g + Consulting Europe Limited

More information

COMPLIANCE WITH EU ANNEX 15: VALIDATION AND QUALIFICATION

COMPLIANCE WITH EU ANNEX 15: VALIDATION AND QUALIFICATION COMPLIANCE WITH EU ANNEX 15: VALIDATION AND QUALIFICATION Paul L. Pluta, PhD Journal of Validation Technology Journal of GXP Compliance University of Illinois at Chicago (UIC) College of Pharmacy, Chicago,

More information

QbD Concepts Applied to Qualification and Transfer of Analytical Methods

QbD Concepts Applied to Qualification and Transfer of Analytical Methods QbD Concepts Applied to Qualification and Transfer of Analytical Methods CMC Strategy Forum Latin America - 2014 Patrick Swann Senior Director Technical Development QbD = Quality by Design QbD - A systematic

More information

Cleaning Validation in a Biologics Facility Case Study. CBE Pty Ltd

Cleaning Validation in a Biologics Facility Case Study. CBE Pty Ltd Cleaning Validation in a Biologics Facility Case Study CBE Pty Ltd This training program is copyright to CBE Pty Ltd and may not be modified, reproduced, sold, loaned, hired or traded in any form without

More information

Strategic Implantation of PAT : FDA Perspective

Strategic Implantation of PAT : FDA Perspective Strategic Implantation of PAT : FDA Perspective Moheb M. Nasr, Ph.D. CDER, FDA MOHEB.NASR@FDA.HHS.GOV IFPAC 2008 Strategic Implantation of PAT Baltimore, MD January 27, 2008 Outline The Desired State -

More information

Enabling Improvement through the Product Lifecycle: Change Management within a PQS

Enabling Improvement through the Product Lifecycle: Change Management within a PQS Enabling Improvement through the Product Lifecycle: Change Management within a PQS Denise DiGiulio, Senior Advisor OPQ Office of Process and Facilities PDA Chapter Meeting Melbourne, Australia April 3,

More information

Overview of Statistics used in QbD Throughout the Product Lifecycle

Overview of Statistics used in QbD Throughout the Product Lifecycle Overview of Statistics used in QbD Throughout the Product Lifecycle August 2014 The Windshire Group, LLC Comprehensive CMC Consulting Presentation format and purpose Method name What it is used for and/or

More information

ICH Q8/Q8(R)

ICH Q8/Q8(R) Pharmaceutical Quality for the 21 st Century Temple University May 06, 2008 Joseph Famulare, Deputy Director FDA CDER Office of Compliance CDER Office of Compliance and the Critical Path Initiative Since

More information

A Hands-On Guide to Ultrafiltration/ Diafiltration Optimization using Pellicon Cassettes

A Hands-On Guide to Ultrafiltration/ Diafiltration Optimization using Pellicon Cassettes Application Note A Hands-On Guide to Ultrafiltration/ Diafiltration Optimization using Pellicon Cassettes In ultrafiltration (UF) tangential flow filtration (TFF) systems, operating parameter selection

More information

Guidance for Industry Process Validation: General Principles and Practices. F. Hoffman-La Roche, Ltd.

Guidance for Industry Process Validation: General Principles and Practices. F. Hoffman-La Roche, Ltd. Guidance for Industry Process Validation: General Principles and Practices D M k T k Dr. Mark Tucker, F. Hoffman-La Roche, Ltd. Disclosures I am currently a Senior Technical Advisor at F. Hoffman -La Roche.

More information

Quality by Design for Legacy Products A Contradiction?

Quality by Design for Legacy Products A Contradiction? Quality by Design for Legacy Products A Contradiction? Qualification and Verification of Manufacturing Process throughout the Product Life Cycle Dr. Joerg Gampfer WCBP 2015- CASSS Conference Washington

More information

Scibond SL-23 Polymeric Lubrication System for Tube Drawing

Scibond SL-23 Polymeric Lubrication System for Tube Drawing Scibond SL-23 Polymeric Lubrication System for Tube Drawing I. Introduction: Scibond SL-23 is a novel water-based a polymeric lubrication system. It was developed under National Science Foundation grant

More information

Equipment Design Consideration for Cleaning & Cleaning Validation

Equipment Design Consideration for Cleaning & Cleaning Validation Equipment Design Consideration for Cleaning & Cleaning Validation Gamal Amer, Ph. D. Principal Premier Compliance Services, Inc. All rights reserved. Do not copy without permission. 1 Cleaning and Cleaning

More information

A COMPARATIVE FRAMEWORK BETWEEN NEW PRODUCT & LEGACY PRODUCT PROCESS VALIDATION

A COMPARATIVE FRAMEWORK BETWEEN NEW PRODUCT & LEGACY PRODUCT PROCESS VALIDATION A COMPARATIVE FRAMEWORK BETWEEN NEW PRODUCT & LEGACY PRODUCT PROCESS VALIDATION By Mark Mitchell, Principal Consultant, Process and Engineering, Pharmatech Associates, Inc. PHARMATECH WHITE PAPER.DOCX

More information

Lifecycle Approach to Process Validation

Lifecycle Approach to Process Validation Lifecycle Approach to Process Validation Best Practices and Strategies July 19 th, 2016 Patrick Donohue, Drug Product Development, Janssen R&D Disclaimer The contents of this presentation are my personal

More information

Bioreactor Process Control Principles from Lab to Industrial Scale. Daniel Egger & Manfred Zinn

Bioreactor Process Control Principles from Lab to Industrial Scale. Daniel Egger & Manfred Zinn Bioreactor Process Control Principles from Lab to Industrial Scale Daniel Egger & Manfred Zinn Agenda What is industrial production Scale up importance Classic scale up principles Problems in industrial

More information

Inline Conditioning system

Inline Conditioning system GE Healthcare Frequently asked questions Inline Conditioning system Buffer preparation can be both time-and spaceconsuming and can easily become a challenge in biomanufacturing. In-line preparation of

More information

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY ISSN Review Article

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY  ISSN Review Article INTERNATIONAL RESEARCH JOURNAL OF PHARMACY www.irjponline.com ISSN 2230 8407 Review Article INTRODUCTION AND GENERAL OVERVIEW OF PHARMACEUTICAL PROCESS VALIDATION: A REVIEW Pandita Rachna* 1, Rana A C

More information

Cleaning Validation for Aseptic Manufacturing Equipment

Cleaning Validation for Aseptic Manufacturing Equipment Cleaning Validation for Aseptic Manufacturing Equipment Michelle Monk, Engineer Rizwan Sharnez, Ph.D., Scientific Director Amgen Advances in Aseptic Processing March 10-12, 2014 San Diego, CA Overview

More information

MASTER PLANNING FOR VALIDATION

MASTER PLANNING FOR VALIDATION MASTER PLANNING FOR VALIDATION By: Gamal Amer, Ph.D. Principal, Premier Compliance Services, Inc. 1 Process Validation: General Principles and Practices Guidance to industry issued by the FDA in January

More information

Paradigm Shift in Comparability Assessment:

Paradigm Shift in Comparability Assessment: Paradigm Shift in Comparability Assessment: How Quality by Design (QbD) and Process Analytical Technology (PAT) can improve Structure-Activity Relationship (SAR) evaluation and its relevance to comparability

More information

Lifecycle Management of Process Analytical Technology Procedures

Lifecycle Management of Process Analytical Technology Procedures Lifecycle Management of Process Analytical Technology Procedures IFPAC 2015 Marta Lichtig Senior Scientist in New Testing Technologies, ACS Member Contents General Comparison : PV guide to NIR model development

More information

Cleaning Validation: A Timely Solution for Improving Quality and Containing Cost

Cleaning Validation: A Timely Solution for Improving Quality and Containing Cost : A Timely Solution for Improving Quality and Containing Cost by Christopher Crone This article presents an economic case for the use of on-line Total Organic Carbon (TOC) and conductivity analysis for

More information

Subject Index. chromatography step, 125-

Subject Index. chromatography step, 125- A Alert limits, description, 70 Aluminum hydroxide based vaccine manufacture, start up and validation of sterile formulation and filling processes, 144-168 Anion-exchange chromatography step for clinical-grade

More information

FDA s Guidance for Industry

FDA s Guidance for Industry Sterile Drug Products Produced by Aseptic Processing - CGMPs Midwest FDC Conference November 4 2005 Susan Bruederle, Investigator FDA / ORA / Central Region Chicago District / Hinsdale IL FDA s Guidance

More information

Media Fill A Process Simution. Presented By Shikha Chauhan

Media Fill A Process Simution. Presented By Shikha Chauhan Media Fill A Process Simution Presented By Shikha Chauhan 21 CFR 211.113 Validation of Aseptic Processing and Sterilization Process Simulation / Media Fill Filtration Efficacy Sterilization of Equipment,

More information

CT425 Optimize Your Process to Make Profits

CT425 Optimize Your Process to Make Profits - 5058-CO900H 1 CT425 Optimize Your Process to Make Profits Rockwell s Model Predictive Control Technology Aaron Dodgson Pavilion Business Development Western Region aadodgson@ra.rockwell.com PUBLIC 2

More information

Replacing Analytical Methods for Release and Stability Testing CBER Perspective

Replacing Analytical Methods for Release and Stability Testing CBER Perspective Replacing Analytical Methods for Release and Stability Testing CBER Perspective Presentation at the CMC Strategy Forum January 27, 2014 Lokesh Bhattacharyya Chief, Lab of Analytical Chemistry and Blood

More information

CIP Cleaning in the. The ASME Guide for Bioprocessing Equipment (BPE 2007) and CIP Design. Full TACCT functionality

CIP Cleaning in the. The ASME Guide for Bioprocessing Equipment (BPE 2007) and CIP Design. Full TACCT functionality CIP Cleaning in the Life Science Industry The ASME Guide for Bioprocessing Equipment (BPE 2007) and CIP Design Decentralized CIP System Design with Full TACCT functionality Agenda Cleaning in the Life

More information

PDA: A Global. Association. Matrix Approach to Media Fills. (c) 2012 Catalent Pharma Solutions. All rights reserved.

PDA: A Global. Association. Matrix Approach to Media Fills. (c) 2012 Catalent Pharma Solutions. All rights reserved. PDA: A Global Matrix Approach to Media Fills Association (c) 2012 Catalent Pharma Solutions. All rights reserved. Overview Guidance Overview Matrix Introduction Why Matrix Media Fills Sample Matrix New

More information

Multi-column Continuous Capture Chromatography New data confirming significant savings and de-bottlenecking opportunities

Multi-column Continuous Capture Chromatography New data confirming significant savings and de-bottlenecking opportunities Multi-column Continuous Capture Chromatography New data confirming significant savings and de-bottlenecking opportunities Dr.-Ing. Kathleen Mihlbachler, LEWA Bioprocess Repligen Seminar: Advances in Bioprocessing,

More information

Identifying and Controlling CPPs and CMAs

Identifying and Controlling CPPs and CMAs March 2018, BioPharm International Publication Identifying and Controlling CPPs and CMAs Thomas A. Little Ph.D. 2/22/2018 President/CEO Thomas A. Little Consulting, BioAssay Sciences 12401 N Wildflower

More information

The Cleaning Validation Process

The Cleaning Validation Process The Cleaning Validation Process The Scope of Cleaning Validation The Cleaning Validation Sequence Prerequisites Cleaning Validation Strategy, Plan, and Policy Sampling Recovery Studies Analytical Method

More information

Current FDA Perspective for Continuous Manufacturing

Current FDA Perspective for Continuous Manufacturing Current FDA Perspective for Continuous Manufacturing Sau (Larry) Lee, Ph.D. Deputy Director (Acting) & Emerging Technology Team Chair Office of Testing and Research Office of Pharmaceutical Quality US

More information

Single-Use Final Fill: Benefits and Considerations

Single-Use Final Fill: Benefits and Considerations Single-Use Final Fill: Benefits and Considerations TENDÊNCIAS DE TECNOLOGIAS DE FABRICAÇÃO E ASSÉPTICA DE MEDICAMENTOS Ana Luísa Lampert Cadore Sales Specialist SU & Aseptic Process Solutions ana.cadore@merckgroup.com

More information

PMDA Perspective: Regulatory Updates on Process Validation Standard

PMDA Perspective: Regulatory Updates on Process Validation Standard CMC Strategy Forum Japan 2014 Tokyo, Japan, December 8-9, 2014 PMDA Perspective: Regulatory Updates on Validation Standard Kazunobu Oyama, PhD Office of Cellular and Tissue-based Products PMDA, Japan Disclaimer:

More information

The Risk Management + Design Controls Connection: What Device Makers Need to Know

The Risk Management + Design Controls Connection: What Device Makers Need to Know !!! The Risk Management + Design Controls Connection: What Device Makers Need to Know Jon Speer Founder & VP of QA/RA greenlight.guru Table of Contents 1 Intended Use & User Needs 6 Verification, Validation,

More information

Continuous Manufacturing: An Industry View

Continuous Manufacturing: An Industry View Novartis Pharmaceuticals Continuous Manufacturing: An Industry View Diane Zezza Novartis Pharmaceuticals FDA/PQRI Conference on Advancing Product Quality March 22, 2017 Where are we today? Continuous Manufacturing

More information

Designing an effective cleaning procedure for medical devices through laboratory studies

Designing an effective cleaning procedure for medical devices through laboratory studies Designing an effective cleaning procedure for medical devices through laboratory studies Elizabeth Rivera Technical Service Specialist STERIS Corporation elizabeth_rivera@steris.com October 2012 Agenda

More information

DHX Heat Exchanger. A new solution to heat transfer

DHX Heat Exchanger. A new solution to heat transfer DHX Heat Exchanger A new solution to heat transfer Sterile, efficient and modular The Thermo Scientific DHX Heat Exchanger is a modular system that employs a plate-and-frame concept, using a single-use

More information

Annex Draft Annex

Annex Draft Annex Anmerkung 1: Dieses Vergleichsdokument wurde nach bestem Wissen und Gewissen erstellt und ist rechtlich nicht bindend. Es gelten die von der EMA veröffentlichten Dokumente in der jeweiligen Form. Anmerkung

More information

Current Features of USFDA and EMA Process Validation Guidance

Current Features of USFDA and EMA Process Validation Guidance Human Journals Review Article April 2016 Vol.:6, Issue:1 All rights are reserved by Patwekar S.L et al. Current Features of USFDA and EMA Process Validation Guidance Keywords: Pharmaceutical validation,

More information

Replacing Analytical Methods for Release and Stability Testing A Regulatory Perspective

Replacing Analytical Methods for Release and Stability Testing A Regulatory Perspective Replacing Analytical Methods for Release and Stability Testing A Regulatory Perspective Presentation at The IVT s 12 th Annual Analytical Procedure and Method Validation Conference Dec 12, 2016 Lokesh

More information

Principal approach to CPV :

Principal approach to CPV : Principal approach to CPV : Integration with Quality Systems & Operating Mechanisms J. Gampfer, Baxalta, Vienna Austria Baxalta Principal Approach to CPV J. Gampfer Page 1 Baxalta Principal Approach to

More information

LabChip GXII: Antibody Analysis

LabChip GXII: Antibody Analysis WHITE PAPER LabChip GXII: Antibody Analysis Antibody Analysis using microfluidic technology in high throughput Quality by Design Experiments Abstract Current initiatives in Process Analytical Technology

More information

Regulatory Pathways. Devices vs. Drugs Are there roles for registries? John Laschinger, MD CDRH/ODE/DCD/SHDB

Regulatory Pathways. Devices vs. Drugs Are there roles for registries? John Laschinger, MD CDRH/ODE/DCD/SHDB Regulatory Pathways Devices vs. Drugs Are there roles for registries? John Laschinger, MD CDRH/ODE/DCD/SHDB johnlaschinger@fda.hhs.gov 1 Disclosures and Disclaimer John C. Laschinger, M.D. I am a full

More information

Whitepaper Design for Cleaning

Whitepaper Design for Cleaning Whitepaper Design for Cleaning FOR PHARMACEUTICAL MANUFACTURING SYSTEMS I N D U S T R Y I N S I G H T S Stephen Hall, PE Sr. Process Engineer I N D U S T R Y I N S I G H T S Genesis periodically publishes

More information

QbD (Quality by Design) Has industry benefited from this? WHITE PAPER.

QbD (Quality by Design) Has industry benefited from this? WHITE PAPER. WHITE PAPER www.makrocare.com/consulting There are many facets to engineering for a healthier world. It is important to understand what surrounds us today and look into what we believe will surround us

More information

THE NEW QUALITY PARADIGM OPPORTUNITIES AND EXPECTATIONS IN ICH Q8 Q9 Q10 Q11 DR. FRITZ ERNI

THE NEW QUALITY PARADIGM OPPORTUNITIES AND EXPECTATIONS IN ICH Q8 Q9 Q10 Q11 DR. FRITZ ERNI THE NEW QUALITY PARADIGM IN ICH Q8 Q9 Q10 Q11 OPPORTUNITIES AND EXPECTATIONS DR. FRITZ ERNI FRITZ@ERNI.NET THE NEW PARADIGM OR QUALITY BY DESIGN Why do we need it! Some background Information The impact

More information

Guidelines for Process Validation of Pharmaceutical Dosage Forms

Guidelines for Process Validation of Pharmaceutical Dosage Forms Guidelines for Process Validation of Pharmaceutical Dosage Forms Version 2.1 Date issued 21/02/2010 Date of implementation 21/05/2010 31 August 2010 Page 1 of 20 Guidelines for Process Validation of Pharmaceutical

More information

CLOSED-LOOP HEAT EXCHANGER FOR GROUND COUPLED HEAT PUMPS

CLOSED-LOOP HEAT EXCHANGER FOR GROUND COUPLED HEAT PUMPS Bulletin of the Transilvania University of Braşov Vol. () - 0 Series : Special Issue No. CLOSED-LOOP HEAT EXCHANGER FOR GROUND COUPLED HEAT PUMPS G. DRAGOMIR I. BOIAN V. CIOFOAIA Abstract: Hydraulic imbalances

More information

The Use of Walnut Shell Filtration with Enhanced Synthetic Media for the Reduction and/or Elimination of Upstream Produced Water Treatment Equipment

The Use of Walnut Shell Filtration with Enhanced Synthetic Media for the Reduction and/or Elimination of Upstream Produced Water Treatment Equipment Siemens Water Solutions The Use of Walnut Shell Filtration with Enhanced Synthetic Media for the Reduction and/or Elimination of Upstream Produced Water Treatment Equipment White Paper January 2016 Researchers

More information

Continuous Pharmaceutical Manufacturing: CGMP, Process Validation, and Inspectional Considerations for Implementation

Continuous Pharmaceutical Manufacturing: CGMP, Process Validation, and Inspectional Considerations for Implementation Continuous Pharmaceutical Manufacturing: CGMP, Process Validation, and Inspectional Considerations for Implementation Christina Capacci-Daniel, Ph.D. Consumer Safety Officer / Acting Quality Assessment

More information

QbD and the New Process Validation Guidance

QbD and the New Process Validation Guidance Page 1 of 6 Published on Pharmaceutical Processing (http://www.pharmpro.com) Home > QbD and the New Process Validation Guidance QbD and the New Process Validation Guidance Bikash Chatterjee and Wai Wong,

More information

PMDA Views on Applying Continuous Manufacturing to Pharmaceutical Products for Industry (provisional draft)

PMDA Views on Applying Continuous Manufacturing to Pharmaceutical Products for Industry (provisional draft) PMDA Views on Applying Continuous Manufacturing to Pharmaceutical Products for Industry (provisional draft) March 30, 2018 Pharmaceuticals and Medical Devices Agency Innovative Manufacturing Technology

More information

Conducting Supplier Audits: Ensure Validation Compliance

Conducting Supplier Audits: Ensure Validation Compliance Conducting Supplier Audits: Ensure Validation Compliance Presented by: Gamal Amer, Ph. D. Principal Premier Compliance Services, Inc. All rights reserved. Do not copy without permission. 1 Outline Why

More information

Regulatory Updates for Biopharmaceutical Products:FDA Perspective

Regulatory Updates for Biopharmaceutical Products:FDA Perspective Regulatory Updates for Biopharmaceutical Products:FDA Perspective CMC Strategy Forum Europe 2016 Sarah Kennett Division of Biotechnology Review and Research I Office of Biotechnology Products OPQ,CDER,

More information

Comparability Studies for Autologous Cell Therapy Products. Chris Shen July, 2017

Comparability Studies for Autologous Cell Therapy Products. Chris Shen July, 2017 Comparability Studies for Autologous Cell Therapy Products Chris Shen July, 2017 Forward Looking Statements/Safe Harbor To the extent statements contained in this presentation are not descriptions of historical

More information

Driving Value through Innovation in Biotech Manufacturing. Agenda

Driving Value through Innovation in Biotech Manufacturing. Agenda Driving Value through Innovation in Biotech Manufacturing Jorg Thommes, PhD Senior Vice President Operations Technology and Innovation Biogen 7 October 2015 Agenda Biopharma Legacy, Trends, & Challenges

More information

ISPE S GUIDES AND HOW THEY APPLY TO CLEANING AND CLEANING VALIDATION

ISPE S GUIDES AND HOW THEY APPLY TO CLEANING AND CLEANING VALIDATION ISPE S GUIDES AND HOW THEY APPLY TO CLEANING AND CLEANING VALIDATION Stephanie A. Wilkins, PE ISPE NORDIC CLEANING VALIDATION CONFERENCE 20 April 2016 Objectives > ISPE s Risk-MaPP Guide and its impact

More information

Scale-up & scale-down between the two. worlds of shaken and stirred bioreactors

Scale-up & scale-down between the two. worlds of shaken and stirred bioreactors Scale-up & scale-down between the two worlds of shaken and stirred bioreactors Prof. Dr.-Ing. Jochen Büchs AVT - Biochemical Engineering, RWTH Aachen University Sammelbau Biologie, D - 52074 Aachen, Germany

More information

Eden Approach To Bioprocess Characterisation. Philip Mellors p USP Development & Transfer Team Leader

Eden Approach To Bioprocess Characterisation. Philip Mellors p USP Development & Transfer Team Leader Eden Approach To Bioprocess Characterisation Philip Mellors p USP Development & Transfer Team Leader Process Characterisation What is Process Characterisation? A late stage study that evaluates the process

More information

Quality Risk Management (ICH Q9): WHO Model for Sustainable Quality Medicines

Quality Risk Management (ICH Q9): WHO Model for Sustainable Quality Medicines Quality Risk Management (ICH Q9): WHO Model for Sustainable Quality Medicines Longe Sunday Anthony Head- Quality Assurance May & Baker Nigeria Plc. Pharmacentre, Ota, Nigeria eaglesconsult@gmail.com; Slonge@may-

More information

Cleaning Validation PRODUCT OVERVIEW

Cleaning Validation PRODUCT OVERVIEW PRODUCT OVERVIEW E700 SERIES SUCCESS IN PHARMA Prozess has established itself as a leader in the technically challenging and regulatory complex pharmaceutical sector, and includes 16 of the top 20 global

More information

Improvement of the robustness of the purification process of the intravenous immunoglobulin product (10%) Gammagard Liquid/Kiovig

Improvement of the robustness of the purification process of the intravenous immunoglobulin product (10%) Gammagard Liquid/Kiovig Improvement of the robustness of the purification process of the intravenous immunoglobulin product (10%) Gammagard Liquid/Kiovig Baxter BioScience F. Hupet, E. Felix, J. Van Malleghem, D. Delplace, C.

More information

quantitate host cell DNA with high sensitivity and throughput resdnaseq Host Cell DNA Quantitation Systems: CHO, E.

quantitate host cell DNA with high sensitivity and throughput resdnaseq Host Cell DNA Quantitation Systems: CHO, E. quantitate host cell DNA with high sensitivity and throughput resdnaseq Host Cell DNA Quantitation Systems: CHO, E. coli, Vero, NS0 Precision counts Integrated real-time qpcr systems for quantitation of

More information

22 January Division of Dockets Management (HFA 305) Food and Drug Administration 5630 Fishers Lane, rm Rockville, MD 20852

22 January Division of Dockets Management (HFA 305) Food and Drug Administration 5630 Fishers Lane, rm Rockville, MD 20852 22 January 2009 Division of Dockets Management (HFA 305) Food and Drug Administration 5630 Fishers Lane, rm. 1061 Rockville, MD 20852 SUBMISSION OF COMMENTS, DOCKET NO. FDA-2008-D-0559 Dear Sir or Madam:

More information

Application of Quality by Design (QbD) in product development. James E. Polli September 16, 2015

Application of Quality by Design (QbD) in product development. James E. Polli September 16, 2015 Application of Quality by Design (QbD) in product development James E. Polli jpolli@rx.umaryland.edu September 16, 2015 Pharmaceutical Equivalence Same active ingredient(s) Same dosage form Same route

More information

Proven Flow Measurement Solutions for the Oil and Gas Industry

Proven Flow Measurement Solutions for the Oil and Gas Industry Proven Flow Measurement Solutions for the Oil and Gas Industry For The Real World., Berkshire, RG6 4UT. UK. 1 The V-Cone flow meter is an advanced technology that takes differential pressure flow measurement

More information

Lifecycle Management Concepts to analytical Procedures: A compendial perspective. Horacio Pappa, Ph.D. Director - General Chapters U.S.

Lifecycle Management Concepts to analytical Procedures: A compendial perspective. Horacio Pappa, Ph.D. Director - General Chapters U.S. Lifecycle Management Concepts to analytical Procedures: A compendial perspective Horacio Pappa, Ph.D. Director - General Chapters U.S. Pharmacopeia USP Definitions Validation of Compendial Procedures

More information

Manual: 038. Cleaning and Cleaning Validation of API Plant and Equipment

Manual: 038. Cleaning and Cleaning Validation of API Plant and Equipment Title: Cleaning and Cleaning Validation of API Plant and Equipment Manual Number: 38 Prepared by: Date: Supersedes: Checked by: Date: Date Issued: Approved by: Date: Review Date: Manual: 38 Cleaning and

More information

9. Verification, Validation, Testing

9. Verification, Validation, Testing 9. Verification, Validation, Testing (a) Basic Notions (b) Dynamic testing. (c) Static analysis. (d) Modelling. (e) Environmental Simulation. (f) Test Strategies. (g) Tool support. (h) Independent Verification

More information

Fermenter System Bioreactor Lab / Pilot / Industrial Fermenter Automation Fermenter System

Fermenter System Bioreactor Lab / Pilot / Industrial Fermenter Automation Fermenter System Fermenter System Bioreactor Lab / Pilot / Industrial Fermenter Automation Fermenter System About us CNS Co., Ltd. has reached exclusive position in fermenter development, design, and manufacturing area.

More information

Optimization of ADC Process Development. Eric LACOSTE PhD, Chemistry and Biotechnology Development Sanofi Aventis R&D, Vitry sur Seine, France 2016

Optimization of ADC Process Development. Eric LACOSTE PhD, Chemistry and Biotechnology Development Sanofi Aventis R&D, Vitry sur Seine, France 2016 Optimization of ADC Process Development Eric LACOSTE PhD, Chemistry and Biotechnology Development Sanofi Aventis R&D, Vitry sur Seine, France 2016 Strictly confidential do not distribute without prior

More information

Laboratory OOS Investigations The Missing Link

Laboratory OOS Investigations The Missing Link Laboratory OOS Investigations The Missing Link India Pharmaceutical Alliance Carmelo Rosa, Psy.D Director Division of Drug Quality I November 6-17, 2017 Indian Pharmaceutical Alliance DISCLAIMER: The views

More information

FDA Case for Quality MDDA Pilot. November 15, 2017 Rob Becker Director, Quality Edwards Lifesciences

FDA Case for Quality MDDA Pilot. November 15, 2017 Rob Becker Director, Quality Edwards Lifesciences FDA Case for Quality MDDA Pilot November 15, 2017 Rob Becker Director, Quality Edwards Lifesciences Why participate in the MDDA pilot? FDA & Edwards Lifesciences Mission Patients should have access to

More information

Reliability Engineering. RIT Software Engineering

Reliability Engineering. RIT Software Engineering Reliability Engineering Reliability Engineering Practices Define reliability objectives Use operational profiles to guide test execution Preferable to create automated test infrastructure Track failures

More information

CMS, FDA and AAMI Requirements for Bicarbonate Systems Made Simple. Compiled January 2012 by AmeriWater Incorporated

CMS, FDA and AAMI Requirements for Bicarbonate Systems Made Simple. Compiled January 2012 by AmeriWater Incorporated CMS, FDA and AAMI Requirements for Bicarbonate Systems Made Simple Compiled January 2012 by AmeriWater Incorporated Background on the Standards FDA, 21 CFR Sec. 876.5820(a) states that hemodialysis systems

More information

Walnut Shell Filter Reuse Potential

Walnut Shell Filter Reuse Potential Walnut Shell Filter Reuse Potential Mike Howdeshell Chris Catalanotto Eric Lorge Page 1 Introduction / Content Contents Introduction Walnut Shell Filter Basics Off-Shore Pilot Test On-Shore Pilot Test

More information

The long anticipated draft of the FDA s

The long anticipated draft of the FDA s This article provides an overview of the draft guidance, the key changes in relation to the 1987 guidance, and reviews its potential impact on the current industry approaches to science- and risk-based

More information

Quality Implementation Working Group on Q8, Q9 and Q10 Questions & Answers

Quality Implementation Working Group on Q8, Q9 and Q10 Questions & Answers INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE Quality Implementation Working Group on Q8, Q9 and Q10 & Current version dated June

More information

Brief Summary of Last Lecture. Model checking of timed automata: general approach

Brief Summary of Last Lecture. Model checking of timed automata: general approach Brief Summary of Last Lecture Formal verification Types: deductive (theorem proving) and algorithmic (model checking) ields proof that a (formal) specification is fulfilled Formalization of specs e.g.

More information

Application of PAT for Tablet Analysis. Case examples from Novartis Lorenz Liesum, Lead PAT Hamburg, 19 th of April 2013

Application of PAT for Tablet Analysis. Case examples from Novartis Lorenz Liesum, Lead PAT Hamburg, 19 th of April 2013 Application of PAT for Tablet Analysis Case examples from Novartis Lorenz Liesum, Lead PAT Hamburg, 19 th of April 2013 Agenda PAT@Novartis Organization Business Drivers and Cases NIR Spectroscopy for

More information

Filtration of Cell Culture Growth Media and Process Buffers

Filtration of Cell Culture Growth Media and Process Buffers Customer Application Brief Bioprocess, Biologicals, & Pharmaceutical Filtration of Cell Culture Growth Media and Process Buffers Introduction Media feeds and process buffers are two universal additives

More information

Compounding Pharmacies and Water

Compounding Pharmacies and Water Compounding Pharmacies and Water Scott Sutton, PhD scott.sutton@microbiol.org August 21, 2014 46 Disclaimer I am an independent consultant. I have been involved with USP for many years. I do not represent

More information

Product, Process Knowledge & SPC: PV Lifecycle Approach IFPAC January 2016, Arlington, VA

Product, Process Knowledge & SPC: PV Lifecycle Approach IFPAC January 2016, Arlington, VA Product, Process Knowledge & SPC: PV Lifecycle Approach IFPAC January 2016, Arlington, VA Naheed Sayeed Manager, Technical Operations Process Validation, Apotex Inc. 1 Process Validation Life Cycle Stage

More information

Advancements on implementation of single use technology in vaccine manufacturing

Advancements on implementation of single use technology in vaccine manufacturing Advancements on implementation of single use technology in vaccine manufacturing October 25 th, 2013 DCVMN Meeting Rio de Janeiro, Brazil Outline Overview of single use products Applications of single

More information

Partner with the Global Leader in Drug Delivery Systems

Partner with the Global Leader in Drug Delivery Systems 3M DRUG DELIVERY SYSTEMS Partner with the Global Leader in Drug Delivery Systems Northridge, CA, USA Manufacturing Facility Experts at Commercializing Innovation 3M: Transforming New Ideas into Thousands

More information

Transient and Succession-of-Steady-States Pipeline Flow Models

Transient and Succession-of-Steady-States Pipeline Flow Models Transient and Succession-of-Steady-States Pipeline Flow Models Jerry L. Modisette, PhD, Consultant Jason P. Modisette, PhD, Energy Solutions International This paper is copyrighted to the Pipeline Simulation

More information

Overview of Amgen s CQP Commissioning and Qualification Program Steve Wisniewski Principal Compliance Consultant, CAI Past Chairman ISPE C&Q COP

Overview of Amgen s CQP Commissioning and Qualification Program Steve Wisniewski Principal Compliance Consultant, CAI Past Chairman ISPE C&Q COP May 1-3, 2012 Javits Center New York, NY Introduction to ISPE GUIDE: SCIENCE AND RISK-BASED APPROACH FOR THE DELIVERY OF FACILITIES, SYSTEMS, AND EQUIPMENT & Overview of Amgen s CQP Commissioning and Qualification

More information

Process Validation Guidelines. Report highlights 23 rd February 2018

Process Validation Guidelines. Report highlights 23 rd February 2018 Process Validation Guidelines Report highlights 23 rd February 2018 Process validation is an important element of pharmaceutical quality system An effective system provides assurance of the continued capability

More information

Introduction and Revision of IEC 61508

Introduction and Revision of IEC 61508 Introduction and Revision of IEC 61508 Ron Bell OBE, BSc, CEng FIET Engineering Safety Consultants Ltd Collingham House 10-12 Gladstone Road Wimbledon London, SW19 1QT UK Abstract Over the past twenty-five

More information

Annex A2. Guidance on Process Validation Scheme for Aseptically Processed Products

Annex A2. Guidance on Process Validation Scheme for Aseptically Processed Products Annex A2 Guidance on Process Validation Scheme for Aseptically Processed Products 1 Table of content 1 PURPOSE... 3 2 SCOPE... 3 3 GENERAL INFORMATION... 3 4 INFORMATION NEEDED FOR ASEPTIC PROCESSES VALIDATION...

More information

PVP INVESTIGATION OF A SHELL AND TUBE EXCHANGER IN LIQUEFIED NATURAL GAS VAPORIZATION SERVICE

PVP INVESTIGATION OF A SHELL AND TUBE EXCHANGER IN LIQUEFIED NATURAL GAS VAPORIZATION SERVICE ASME PVP 2007/CREEP 8 Conference 2007 ASME Pressure Vessels and Piping Division Conference July 22-26, 2007, San Antonio, Texas, USA PVP2007-26592 INVESTIGATION OF A SHELL AND TUBE EXCHANGER IN LIQUEFIED

More information

Module 8 Its Not Just About the Meter and Regulator

Module 8 Its Not Just About the Meter and Regulator Station Types Point of Delivery (POD) Point of Receipt (POR) Industrial Commercial Residential OGA 2015 Regulator Fundamentals Seminar 2 Station Design Information Upstream pipeline MAOP Inlet pressure

More information

Agilent 5100 ICP-OES DUAL VIEW ICP-OES MINUS THE WAIT

Agilent 5100 ICP-OES DUAL VIEW ICP-OES MINUS THE WAIT Agilent 5100 ICP-OES DUAL VIEW ICP-OES MINUS THE WAIT AGILENT 5100 ICP-OES THE FASTEST ICP-OES... EVER. The Agilent 5100 Synchronous Vertical Dual View (SVDV) ICP-OES revolutionizes ICP-OES analysis. With

More information

A Risk-based Approach for In Vitro Companion Diagnostics Device FDA Approval Process Associated with Therapies that have Breakthrough Designation

A Risk-based Approach for In Vitro Companion Diagnostics Device FDA Approval Process Associated with Therapies that have Breakthrough Designation A Risk-based Approach for In Vitro Companion Diagnostics Device FDA Approval Process Associated with Therapies that have Breakthrough Designation A Risk-based Approach for In Vitro Companion Diagnostics

More information

An experimental study of permeability determination in the lab

An experimental study of permeability determination in the lab Petroleum and Mineral Resources 221 An experimental study of permeability determination in the lab E. Lock, M. Ghasemi, M. Mostofi & V. Rasouli Department of Petroleum Engineering, Curtin University, Australia

More information

PHOTO ESSAY: TYPICAL OILFIELD WASTE SITES. Found Worldwide in Countries lacking Environmental Regulatory Authorities

PHOTO ESSAY: TYPICAL OILFIELD WASTE SITES. Found Worldwide in Countries lacking Environmental Regulatory Authorities PHOTO ESSAY: TYPICAL OILFIELD WASTE SITES Found Worldwide in Countries lacking Environmental Regulatory Authorities The PHOTO Essay that follows is repeated all over the world. In this case the National

More information